<?xml version="1.0" encoding="utf-8"?>
<feed xmlns="http://www.w3.org/2005/Atom">
<title>Legal Insider Trading Data | Free and Professional Subscription Services | Insider Insights</title>
<link href="http://www.insiderinsights.com/news/company/atxi" ></link>
<id>urn:uuid:6be0f502-1fd3-2705-4b30-e500b87b0546</id>
<updated>2026-05-12T21:48:50-04:00</updated>
<author>Jonathan Moreland</author>
<subtitle>Profit from legal insider trading. InsiderInsights.com provides free insider trading data tools and resources, and professional grade subscription based real time Form 4 data, analysis and services</subtitle>
<entry>
<title>ATXI: FORTRESS BIOTECH INC (BO) Acquired (JB) 111,209 Shares of AVENUE THERAPEUTICS INC for $0.00 on 1/2</title>
<link href="http://www.insiderinsights.com/company/atxi/avenue-therapeutics-inc/id-6303178" ></link>
<id>urn:uuid:bc036a04-cd14-1e4c-c862-9757dfdd6668</id>
<updated>2026-01-06T16:05:23-05:00</updated>
<summary type="html" ><![CDATA[AVENUE THERAPEUTICS INC (ATXI). Recent Price: $0.53. Mkt Cap:1.7mm. 10D Vol: 2,229]]></summary>
</entry>
<entry>
<title>ATXI: FORTRESS BIOTECH INC (BO) Acquired (JB) 33,724 Shares of AVENUE THERAPEUTICS INC for $0.00 on 3/31</title>
<link href="http://www.insiderinsights.com/company/atxi/avenue-therapeutics-inc/id-6176745" ></link>
<id>urn:uuid:83748da8-6999-7497-c1c1-e8d3b75fb61f</id>
<updated>2025-04-02T16:05:13-04:00</updated>
<summary type="html" ><![CDATA[AVENUE THERAPEUTICS INC (ATXI). Recent Price: $0.53. Mkt Cap:1.7mm. 10D Vol: 2,229]]></summary>
</entry>
<entry>
<title>ATXI: FORTRESS BIOTECH INC (BO) Filed a Form 3, Becoming a Registered Insider at AVENUE THERAPEUTICS INC With Initial Direct Holdings of 294,800</title>
<link href="http://www.insiderinsights.com/company/atxi/avenue-therapeutics-inc/id-6106028" ></link>
<id>urn:uuid:889a3f0b-e571-52ea-6aac-6c0c5ad95639</id>
<updated>2025-01-03T16:21:27-05:00</updated>
<summary type="html" ><![CDATA[AVENUE THERAPEUTICS INC (ATXI). Recent Price: $0.53. Mkt Cap:1.7mm. 10D Vol: 2,229]]></summary>
</entry>
<entry>
<title>ATXI: HERSKOWITZ NEIL (DIR) Sold (S) 23 Shares of AVENUE THERAPEUTICS INC for $2.00 on 12/2</title>
<link href="http://www.insiderinsights.com/company/atxi/avenue-therapeutics-inc/id-6090384" ></link>
<id>urn:uuid:5c69a3e9-eb5e-f58a-84a3-7d3065f2a5eb</id>
<updated>2024-12-03T16:30:17-05:00</updated>
<summary type="html" ><![CDATA[AVENUE THERAPEUTICS INC (ATXI). Recent Price: $0.53. Mkt Cap:1.7mm. 10D Vol: 2,229]]></summary>
</entry>
<entry>
<title>ATXI: KRANZLER JAY D (DIR) Sold (S) 61 Shares of AVENUE THERAPEUTICS INC for $2.24 on 11/5</title>
<link href="http://www.insiderinsights.com/company/atxi/avenue-therapeutics-inc/id-6076959" ></link>
<id>urn:uuid:dac8e3ae-b88b-fac6-dd2e-ec5c4e4d85b9</id>
<updated>2024-11-07T19:12:00-05:00</updated>
<summary type="html" ><![CDATA[AVENUE THERAPEUTICS INC (ATXI). Recent Price: $0.53. Mkt Cap:1.7mm. 10D Vol: 2,229]]></summary>
</entry>
<entry>
<title>ATXI: KRANZLER JAY D (DIR) Bought (B) 500 Shares of AVENUE THERAPEUTICS INC for $2.40-$2.50 on 9/27-9/30</title>
<link href="http://www.insiderinsights.com/company/atxi/avenue-therapeutics-inc/id-6063061" ></link>
<id>urn:uuid:ca86ed46-2c97-179e-e6b1-388595d3e81a</id>
<updated>2024-10-01T16:15:13-04:00</updated>
<summary type="html" ><![CDATA[AVENUE THERAPEUTICS INC (ATXI). Recent Price: $0.53. Mkt Cap:1.7mm. 10D Vol: 2,229]]></summary>
</entry>
<entry>
<title>ATXI: MACLEAN ALEXANDRA (CEO,DIR) Acquired (JB) 170k Shares of AVENUE THERAPEUTICS INC for $0.00 on 9/23</title>
<link href="http://www.insiderinsights.com/company/atxi/avenue-therapeutics-inc/id-6061755" ></link>
<id>urn:uuid:6a579e45-686f-b1c9-4ebb-a12bfe66d2af</id>
<updated>2024-09-25T16:55:21-04:00</updated>
<summary type="html" ><![CDATA[AVENUE THERAPEUTICS INC (ATXI). Recent Price: $0.53. Mkt Cap:1.7mm. 10D Vol: 2,229]]></summary>
</entry>
<entry>
<title>ATXI: JIN DAVID (COO) Acquired (JB) 65k Shares of AVENUE THERAPEUTICS INC for $0.00 on 9/23</title>
<link href="http://www.insiderinsights.com/company/atxi/avenue-therapeutics-inc/id-6061753" ></link>
<id>urn:uuid:c16cc783-9f73-c5a4-4312-50daaa3bec25</id>
<updated>2024-09-25T16:53:41-04:00</updated>
<summary type="html" ><![CDATA[AVENUE THERAPEUTICS INC (ATXI). Recent Price: $0.53. Mkt Cap:1.7mm. 10D Vol: 2,229]]></summary>
</entry>
<entry>
<title>ATXI: FORTRESS BIOTECH INC (BO) Acquired (JB) 413,507 Shares of AVENUE THERAPEUTICS INC for $0.00 on 4/16</title>
<link href="http://www.insiderinsights.com/company/atxi/avenue-therapeutics-inc/id-5982821" ></link>
<id>urn:uuid:b767b70e-a04f-4d02-4583-24a3363c6645</id>
<updated>2024-04-17T16:05:19-04:00</updated>
<summary type="html" ><![CDATA[AVENUE THERAPEUTICS INC (ATXI). Recent Price: $0.53. Mkt Cap:1.7mm. 10D Vol: 2,229]]></summary>
</entry>
<entry>
<title>ATXI: FORTRESS BIOTECH INC (BO) Acquired (JB) 2.1mm Shares of AVENUE THERAPEUTICS INC for $0.00 on 1/2</title>
<link href="http://www.insiderinsights.com/company/atxi/avenue-therapeutics-inc/id-5898606" ></link>
<id>urn:uuid:0273ed15-ed38-7ecf-72b4-a16c60e5c921</id>
<updated>2024-01-03T16:27:48-05:00</updated>
<summary type="html" ><![CDATA[AVENUE THERAPEUTICS INC (ATXI). Recent Price: $0.53. Mkt Cap:1.7mm. 10D Vol: 2,229]]></summary>
</entry>
</feed>